Christopher Liddle
The University of Sydney · 250 works · 22,378 citations · h-index 72
Top works
- NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome
- Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
- The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
- Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands
- PPARγ signaling and metabolism: the good, the bad and the future
- Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation
- Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy
- Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β
- Resolution of Severe Ipilimumab-Induced Hepatitis After Antithymocyte Globulin Therapy
- HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?
- In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
- A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response
- Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index
- An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice
- Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation
- Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer
- Coinfection with hepatitis B and C or B, C and δ viruses results in severe chronic liver disease and responds poorly to terferon‐a treatment
- Genotype‐specific mechanisms for hepatic steatosis in chronic hepatitis C infection